Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Social Security Disability Insurance (SSDI) provides financial support for individuals who cannot work due to severe medical conditions, including immune and autoimmune disorders.
These SSDI immune & autoimmune conditions can lead to significant impairments that disrupt daily life, such as chronic inflammation, severe fatigue, or other complications.
On this page, we’ll provide you with an overview of SSDI immune & autoimmune conditions, medical evidence for SSDI immune condition claims, reassessment of SSDI immune and autoimmune condition benefits, and much more.
Common examples of SSDI immune and autoimmune conditions may include, but are not limited to:
An SSDI applicant must demonstrate through medical evidence that their condition aligns with the SSA’s criteria and prevents them from maintaining gainful employment.
If you or someone you love has experienced one of these immune and/or autoimmune conditions, you may qualify to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine your eligibility to file for SSDI benefits today.
The Social Security Disability Insurance (SSDI) program includes specific provisions and evaluation criteria for individuals with immune and autoimmune disorders.
These conditions, covered under the SSA’s Listing of Impairments section 14.00, require thorough medical documentation to establish the severity and functional limitations imposed by the disorder.
Individuals diagnosed with an immune system disorder may qualify for financial assistance if their condition impairs their ability to work, necessitating proper medical documentation and assessment of limitations related to the disorder.
Applicants must demonstrate how their condition hinders their ability to work through medical evidence and history.
Commonly evaluated conditions include systemic lupus erythematosus, systemic vasculitis, and immune deficiency disorders, among others.
The evaluation focuses on both the activity of the disease and its impact on the individual’s daily functioning.
This involves documenting the frequency, duration, and intensity of symptoms, as well as their overall impact on health.
Medical practitioners often rely on a combination of clinical evaluation and laboratory tests to evaluate the level of disease activity.
This evidence helps Social Security determine whether the criteria under their specific listings, such as systemic lupus erythematosus (14.02) or scleroderma (14.04), are met.
Proper assessment ensures that the disorder’s current severity and expected progression are accurately captured, aligning with SSDI requirements.
Key elements in disease activity assessment for SSDI may include:
These elements are critical as they provide quantifiable data to showcase the ongoing challenges posed by the disorder.
For instance, frequent flare-ups documented over a consistent period can illustrate an inability to maintain stable health, which is indispensable for employment.
Additionally, the effect of treatments and medication response also help highlight the disorder’s manageability and lingering issues.
Accurate and comprehensive documentation of these factors aids in painting a full picture of the claimant’s condition for SSDI consideration.
Functional impact measurement details how the autoimmune disorder affects various aspects of a person’s ability to perform work-related activities.
Social Security considers this in terms of physical, mental, and social functioning.
Tools to measure functionality include daily living assessments and specialized functional capacity evaluations, which objectively outline the extent of limitations.
This measurement helps establish a baseline of incapacity, demonstrating how health impairments hinder job performance and routine activities.
Factors affecting functional impact measurements typically include:
For instance, severe fatigue or pain may limit one’s ability to engage in social activities or complete work assignments consistently.
The SSDI evaluation process relies heavily on these functional insights to justify awarding benefits, ensuring only those individuals significantly impaired by their disorder receive support.
Adequate documentation from healthcare providers substantiates these claims, elucidating the extent of impairment beyond clinical diagnosis.
To qualify for Social Security Disability Insurance (SSDI) based on immune or autoimmune disorders, applicants must provide comprehensive documentation demonstrating the severity and impact of their condition.
The Social Security Administration (SSA) evaluates various factors such as clinical test results, treatment history, and ongoing symptoms.
The SSA uses the Blue Book, which outlines the criteria for evaluation of impairments, including specific immune system disorders like systemic lupus erythematosus, systemic vasculitis, and others.
These results provide objective evidence of the presence and severity of the disorder.
The SSA requires these test results to establish the diagnosis and to verify the claimant’s reported symptoms and functional limitations.
Detailed clinical findings, which may include laboratory tests and imaging, form the foundation of the medical evidence needed by SSA to assess the impairment accurately.
The following clinical test results are typically required:
Submitting comprehensive and up-to-date clinical test results can significantly strengthen the disability claim.
These tests must accurately illustrate the ongoing nature and severity of the disorder, aligning with the symptoms described by the applicant.
Clinical documentation should, therefore, include all relevant updates to support the continued presence and limiting factors of the disorder.
This evidence is critical for the SSA’s assessment of whether the disorder meets the medical criteria outlined in the Blue Book listings.
Records of how an individual with an immune or autoimmune disorder responds to treatment are integral in determining SSDI eligibility.
The SSA examines these records to understand the effectiveness of prescribed therapies and how they impact the claimant’s ability to function.
This includes documenting both improvements and any persistent or worsening symptoms under treatment.
Treatment response records help establish the ongoing constraints imposed by the disorder despite medical interventions.
Key components of treatment response records may include:
Having detailed treatment response records ensures the SSA can effectively evaluate the extent to which an individual’s disorder is controlled or exacerbated by ongoing treatment.
Such records not only highlight the disorder’s trajectory under medical management but also emphasize the areas where the patient continues to experience significant debilitating effects.
These insights can be pivotal in illustrating why an individual remains unable to engage in substantial gainful activity even with treatment, thus supporting their claim for SSDI benefits.
Social Security Disability Insurance (SSDI) eligibility for individuals with immune and autoimmune disorders requires a thorough understanding of specific criteria set by the Social Security Administration (SSA) for social security disability benefits.
These requirements highlight the importance of medical documentation and evidence, particularly in demonstrating the severity and persistence of the disorder and how it limits one’s ability to perform substantial gainful activity.
Both the initial approval process and subsequent monitoring through Continuing Disability Reviews (CDRs) are essential components to ensure that only those who genuinely meet the criteria receive benefits.
The initial approval process for SSDI benefits for immune and autoimmune disorders involves meeting the criteria outlined in the SSA’s Listing of Impairments, often referred to as the “Blue Book.”
SSDI applicants must provide comprehensive medical evidence that demonstrates the severity of their condition and how it impairs their ability to work.
Conditions like systemic lupus erythematosus, systemic vasculitis, and others have specific listings that require detailed medical documentation.
This also includes laboratory test results, physician notes, and any other relevant medical records that support the claim of disability.
Required documentation typically includes:
During the initial evaluation, the SSA considers both the medical and non-medical factors affecting the applicant’s condition.
The evidence gathered must illustrate the chronic and severe nature of the disorder, as well as its continuity over time, to prove that the condition is expected to persist for at least 12 months or result in death.
Understanding and preparing for this phase of the application process can significantly impact the likelihood of securing SSA disability benefits.
Continuing Disability Reviews (CDRs) are periodic checks conducted by the SSA to determine whether SSDI recipients still meet the eligibility criteria.
For individuals with immune and autoimmune disorders, maintaining eligibility often involves ongoing medical reviews to verify the persistence and severity of the condition.
The frequency of these reviews can vary based on the likelihood of medical improvement; some conditions that are deemed unlikely to improve are subject to reviews less frequently.
Nevertheless, the SSA strives to ensure beneficiaries no longer qualify if their medical condition has improved to the extent that they can return to gainful employment.
Aspects of continuing disability reviews include but are not limited to:
Continuing Disability Reviews (CDRs) serve the dual purpose of verifying a claimant’s ongoing need for benefits while also serving as a guard against fraudulent claims.
Beneficiaries are required to cooperate fully during the review process, providing all requested information and attending any necessary examinations.
Failure to comply with CDR requirements can lead to the termination of benefits.
Keeping a comprehensive and updated medical record, along with any changes in the condition or treatment plan, will aid significantly during these reviews to ensure continued qualification for SSDI benefits.
Immune and autoimmune disorders like lupus, rheumatoid arthritis, and immune deficiency disorders can qualify for SSDI benefits if they cause severe limitations.
The Social Security Administration (SSA) requires comprehensive medical evidence showing how these conditions significantly impair an individual’s ability to work and perform daily activities.
Applicants must provide medical records including laboratory tests, physical exams, and documentation of severe symptoms like organ damage or joint involvement.
A qualified healthcare provider’s diagnosis along with evidence of inability to perform substantial gainful activity due to frequent flare-ups is essential.
The SSA evaluates immune deficiency disorders based on documented recurrent infections, complications, and their impact on work capacity.
Applicants must provide detailed medical records showing the disorder’s severity, treatment history, and evidence of serious personal care difficulties.
The SSA examines the frequency of symptom flare-ups, severity of immune system dysfunction, and responses to treatments.
Medical documentation must include blood tests, imaging results, and evidence of how the condition affects organ function.
CDRs are performed periodically based on the likelihood of medical improvement for the specific condition.
The Social Security Administration requires updated medical records, diagnostic tests, and assessment of current symptoms during these reviews to verify ongoing eligibility.
Blood tests showing immune system activity markers, imaging tests like X-rays or MRIs, and detailed reports from immunologists or rheumatologists are typically required.
These tests must demonstrate the ongoing nature and severity of the disorder to meet the SSA’s Blue Book criteria.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
You can learn more about the Social Security Disability Insurance by visiting any of our pages listed below:
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?